Navigation Links
MSI releases 'moleculizer' - a new approach to simulation of intracellular biochemical networks

Dr. Roger Brent, President and Director of Research at the Molecular Sciences Institute ("MSI"), announced today the release of a new approach to simulation of intracellular biochemical networks in the January 2005 edition of Nature Biotechnology. The research article, entitled "Automatic generation of cellular reaction networks with Moleculizer 1.0" (pdf) describes MSI's discrete stochastic event simulator, which keeps track of the thousands of complex species formed from pathway proteins as it simulates reactions between them by a standard Monte Carlo method. A distinguishing aspect of Moleculizer is its ability to generate protein complexes and reactions as they are needed, as opposed to generating all potential complexes and reactions all at once, a task that requires tremendous computer resources beyond the scope of most research labs.

"Moleculizer is a powerful tool that meets a very real need for biologists," explained Dr. Brent. "It is a critical step forward in our quest to provide an accurate simulation of intracellular biochemical networks." "I've designed Moleculizer to be intuitive for biologists," said Dr. Larry Lok, a mathematician who conceived and programmed Moleculizer. "Its parallel simplifications in simulation setup and output provide data in a way that is meaningful and useful to biological researchers." Moleculizer was developed in the context of MSI's "Alpha Project", an ambitious experimental and computational effort to understand the quantitative behavior of a cell signaling pathway in yeast. The Alpha Project is funded by the National Institutes of Health's National Human Genome Research Institute, which designated MSI as a Center of Excellence in Genomic Research. The CEGS program supports multi-investigator, interdisciplinary research teams to develop novel and innovative genomic research projects. "Moleculizer is exactly the sort of development that one wants to see from multidisciplinary work," explained Dr. Brent. "The mathematical and algorithmic skills that Dr. Lok brought to the problem could only come from one with his strengths, but the work is important because it addresses a problem arising directly from the biology." Dr. Daniel Gillespie, a pioneer in stochastic methods for modeling chemical kinetics stated, "Dr. Lok has succeeded in adapting and creatively extending earlier developed techniques for stochastically simulating chemical reactions so that they can be used to study real cellular systems, where the huge numbers of potential species and reaction channels makes things very difficult." Computer simulations can be powerful tools in contemporary molecular biology research, aiding scientists in analyzing data and in testing hypotheses with simulated outcomes before testing them experimentally. The predictive capabilities of computer simulations can also aid biologists in viewing cellular activity over a period of time, by taking advantage of the power of computers to generate the thousands of potential protein complexes and reactions that cells are able to generate. The Molecular Sciences Institute is an independent nonprofit research laboratory that combines genomic experimentation with computer modeling. Work at MSI aims to weave physics, engineering, computer science, and mathematics together with biology and chemistry to enable precise, quantitative, prediction of the future behaviors of biological systems. In keeping with the MSI's support for an open source biology, Moleculizer will be made freely available under the GNU Lesser General Public License. Nature Biotechnology is "a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research."
'"/>

Source:Eurekalert


Related biology news :

1. Agilent Technologies releases automated literature search tool for biology researchers
2. Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays
3. Center releases new public survey on stem cells
4. DOE JGI releases IMG 1.5 with curated archaeal genomes
5. DOE JGI sequences, releases genome of symbiotic tree fungus
6. Triple threat polymer captures and releases
7. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
8. Stopping smallpox in its tracks: A new anti-viral approach
9. Building a protein name dictionary from full text: a machine learning term extraction approach
10. Rensselaer researchers develop approach that predicts protein separation behavior
11. Huntingtons cure in flies lays groundwork for broader treatment approaches

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
(Date:2/6/2017)... -- According to Acuity Market Intelligence, ongoing concerns ... continue to embrace biometric and digital identification based ... Control (ABC) eGates and 1436 Automated Passport Control ... ports of entry across the globe. Deployments increased ... CAGR of 37%. APC Kiosks reached 75% growth ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... FRANCISCO , Feb. 24, 2017 Symic ... is developing a new category of therapeutics, announced today ... of SB-030 in peripheral artery disease. The trial will ... administered single-use therapeutic, in the reduction of restenosis following ... this critical development milestone for SB-030," said Nathan ...
(Date:2/24/2017)... ... February 24, 2017 , ... FireflySci, Inc is an explosive small ... FireflySci had the goal of bringing their powerful cuvette and spectrophotometer calibration ... path that FireflySci is going on as they add yet another mark on the ...
(Date:2/24/2017)... 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a ... Key Opinion Leader event to highlight new clinical data ... presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and ... be held in-person and via live webcast on Tuesday, ... PST at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs is formalizing ... an array of biochemical analyses critical for Lead Discovery. The company’s Lead ... SAR programs, including inhibitor potency and selectivity, mechanism of action, and inhibitor residence ...
Breaking Biology Technology: